Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
What happened?
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Story details
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Why it matters
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.